These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7073948)

  • 41. Effect of misonidazole on the tolerance of the rat spinal cord to daily and multiple fractions per day of X rays.
    van der Kogel AJ; Sissingh HA
    Br J Radiol; 1983 Feb; 56(662):121-5. PubMed ID: 6824830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT; Dembs NL; Ublacker GA
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors influencing the chemosensitization of melphalan by misonidazole.
    Randhawa VS; Stewart FA; Denekamp J; Stratford MR
    Br J Cancer; 1985 Feb; 51(2):219-28. PubMed ID: 3966979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Misonidazole reduces blood flow in two experimental murine tumours.
    Murray JC; Randhawa VS
    Br J Cancer; 1988 Aug; 58(2):128-32. PubMed ID: 3166901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
    Rofstad EK; Brustad T
    Br J Radiol; 1979 May; 52(617):393-7. PubMed ID: 444837
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined effect of misonidazole and glutathione depletion by buthionine sulphoximine on cellular radiation response.
    Edgren M; Nishidai T; Scott OC; Révész L
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Apr; 47(4):463-74. PubMed ID: 3872859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
    Twentyman PR
    Br J Cancer; 1981 Jun; 43(6):745-55. PubMed ID: 6264941
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in Na-K ATPase and protein kinase C activities in peripheral nerve of acrylamide-treated rats.
    Lehning EJ; LoPachin RM; Mathew J; Eichberg J
    J Toxicol Environ Health; 1994 Jul; 42(3):331-42. PubMed ID: 8021966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Enhancement of MeCCNU potency (chemosensitization) by misonidazole in a human melanoma xenograft system].
    Osieka R; Glatte P; Haedecke U; Schmidt CG
    Strahlentherapie; 1982 Oct; 158(10):620-9. PubMed ID: 7179344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of the DNA cross-linking activity of melphalan by misonidazole in vivo.
    Murray D; Meyn RE
    Br J Cancer; 1983 Feb; 47(2):195-203. PubMed ID: 6824567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the anticholinesterase activity of metronidazole and misonidazole.
    Von Burg R; Conroy PJ
    Eur J Pharmacol; 1979 May; 55(4):417-20. PubMed ID: 467496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative studies of hypoxic-cell radiosensitization using artificially hypoxic skin in vivo.
    Denekamp J; Michael BD; Minchinton AI; Smithen CE; Stewart FA; Stratford MR; Terry NH
    Br J Cancer; 1982 Feb; 45(2):247-55. PubMed ID: 7059473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of misonidazole, anaesthesia, clamping of the leg and stress of the animal during treatment on the radiation-induced skin reaction of mouse feet.
    Wondergem J; Haveman J; van der Schueren E
    Int J Radiat Biol Relat Stud Phys Chem Med; 1982 Jun; 41(6):689-95. PubMed ID: 6981623
    [No Abstract]   [Full Text] [Related]  

  • 58. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
    Roizin-Towle LA; Hall EJ
    Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.